Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

- PMLiVE

Jazz offers $1bn for Italy’s Gentium

Will gain access to recently-approved liver drug Defitelio

- PMLiVE

ABPI reprimands for four pharma firms

Allergan, Shire Pharmaceuticals, Gedeon Richter and Sanofi breach Code of Practice

- PMLiVE

BIA: Political compromises could undermine EU trial reform

UK biotech body speaks out on eve of crucial committee hearing

- PMLiVE

The cost of doing business

External pressures, like ‘defensive medicine’, need to be counted when it comes to healthcare costs

Warehousing of HCV patients reaches new high

A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...

Inizio

Brand leaders in RA will lose market share, predict rheumatologists

Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.

Inizio

Bayer symbol

Bayer agrees $2.9bn deal for Algeta to get Xofigo control

Raises initial offer to buy Norweigan pharma company

Merck turns to gamification in diabetes

Working with Ayogo on mobile app to improve adherence

- PMLiVE

GSK’s Anoro first LAMA/LABA approved for COPD in US

Important step towards eventually replacing Seretide/Advair sales

- PMLiVE

AstraZeneca buys BMS out of diabetes alliance

Will spend up to $4.3bn to secure sole rights to Onglyza and Forxiga

- PMLiVE

Digitas appoints Michael Leis

Move backs up its social strategy drive

WPP buys into strategic consultants RAA

Firm also runs symposia in healthcare and other sectors

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links